This step is required for every patientit's a core part of what sets our care apart from a walk-in IV bar
This balance helps clients feel cared for while staying accountable
What makes semaglutide unique among GLP-1 agonists is its modified amino acid sequence and fatty acid side chain, which extends its half-life to approximately seven days
However, people with MS who also have obesity or type 2 diabetes may be candidates for GLP-1 therapy, says Alan David Kaye, MD, PhD, a professor and the vice chair of research in the anesthesiology department at LSU Health in Shreveport, Louisiana
Semaglutide is highly effective, tirzepatide is superior with dual agonism, and retatrutide, with its triple-action mechanism, currently offers the greatest weight loss and best tolerability seen in pharmacotherapy
References Teichman, S